vs

Side-by-side financial comparison of Coterra (CTRA) and DILLARD'S, INC. (DDS). Click either name above to swap in a different company.

Coterra is the larger business by last-quarter revenue ($1.8B vs $1.5B, roughly 1.2× DILLARD'S, INC.). Coterra runs the higher net margin — 20.6% vs 8.8%, a 11.7% gap on every dollar of revenue. On growth, Coterra posted the faster year-over-year revenue change (23.8% vs 2.9%). Over the past eight quarters, Coterra's revenue compounded faster (11.8% CAGR vs -16.9%).

Coterra Energy Inc. is an American energy company engaged in hydrocarbon exploration based in Houston, Texas. The company has operations in the Permian Basin, Marcellus Shale, and the Anadarko Basin.

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

CTRA vs DDS — Head-to-Head

Bigger by revenue
CTRA
CTRA
1.2× larger
CTRA
$1.8B
$1.5B
DDS
Growing faster (revenue YoY)
CTRA
CTRA
+20.9% gap
CTRA
23.8%
2.9%
DDS
Higher net margin
CTRA
CTRA
11.7% more per $
CTRA
20.6%
8.8%
DDS
Faster 2-yr revenue CAGR
CTRA
CTRA
Annualised
CTRA
11.8%
-16.9%
DDS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CTRA
CTRA
DDS
DDS
Revenue
$1.8B
$1.5B
Net Profit
$368.0M
$129.8M
Gross Margin
43.4%
Operating Margin
31.9%
11.5%
Net Margin
20.6%
8.8%
Revenue YoY
23.8%
2.9%
Net Profit YoY
23.9%
4.2%
EPS (diluted)
$0.47
$8.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRA
CTRA
DDS
DDS
Q4 25
$1.8B
$1.5B
Q3 25
$1.8B
$1.5B
Q2 25
$1.7B
$1.5B
Q1 25
$2.0B
$2.0B
Q4 24
$1.4B
$1.4B
Q3 24
$1.3B
$1.5B
Q2 24
$1.3B
$1.5B
Q1 24
$1.4B
$2.1B
Net Profit
CTRA
CTRA
DDS
DDS
Q4 25
$368.0M
$129.8M
Q3 25
$322.0M
$72.8M
Q2 25
$511.0M
$163.8M
Q1 25
$516.0M
$214.4M
Q4 24
$297.0M
$124.6M
Q3 24
$252.0M
$74.5M
Q2 24
$220.0M
$180.0M
Q1 24
$352.0M
$250.5M
Gross Margin
CTRA
CTRA
DDS
DDS
Q4 25
43.4%
Q3 25
36.6%
Q2 25
43.9%
Q1 25
34.9%
Q4 24
42.6%
Q3 24
37.6%
Q2 24
44.6%
Q1 24
36.6%
Operating Margin
CTRA
CTRA
DDS
DDS
Q4 25
31.9%
11.5%
Q3 25
26.8%
6.2%
Q2 25
40.9%
14.0%
Q1 25
34.8%
11.7%
Q4 24
22.5%
11.4%
Q3 24
25.3%
6.5%
Q2 24
23.0%
15.2%
Q1 24
30.7%
13.3%
Net Margin
CTRA
CTRA
DDS
DDS
Q4 25
20.6%
8.8%
Q3 25
18.3%
4.8%
Q2 25
29.5%
10.7%
Q1 25
25.6%
10.6%
Q4 24
20.5%
8.7%
Q3 24
19.5%
5.0%
Q2 24
17.1%
11.6%
Q1 24
24.6%
11.8%
EPS (diluted)
CTRA
CTRA
DDS
DDS
Q4 25
$0.47
$8.31
Q3 25
$0.42
$4.66
Q2 25
$0.67
$10.39
Q1 25
$0.68
$13.41
Q4 24
$0.40
$7.73
Q3 24
$0.34
$4.59
Q2 24
$0.29
$11.09
Q1 24
$0.47
$15.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRA
CTRA
DDS
DDS
Cash + ST InvestmentsLiquidity on hand
$114.0M
$1.1B
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$14.8B
$2.0B
Total Assets
$24.2B
$4.3B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRA
CTRA
DDS
DDS
Q4 25
$114.0M
$1.1B
Q3 25
$98.0M
$1.0B
Q2 25
$192.0M
$900.5M
Q1 25
$186.0M
$717.9M
Q4 24
$2.0B
$980.4M
Q3 24
$843.0M
$946.7M
Q2 24
$1.3B
$817.8M
Q1 24
$1.5B
$808.3M
Total Debt
CTRA
CTRA
DDS
DDS
Q4 25
$3.8B
Q3 25
$3.9B
Q2 25
$4.2B
Q1 25
$4.3B
Q4 24
$3.5B
Q3 24
$2.1B
Q2 24
$2.6B
Q1 24
$2.7B
Stockholders' Equity
CTRA
CTRA
DDS
DDS
Q4 25
$14.8B
$2.0B
Q3 25
$14.7B
$1.9B
Q2 25
$14.6B
$1.9B
Q1 25
$14.2B
$1.8B
Q4 24
$13.1B
$2.0B
Q3 24
$13.0B
$1.9B
Q2 24
$13.0B
$1.9B
Q1 24
$13.1B
$1.7B
Total Assets
CTRA
CTRA
DDS
DDS
Q4 25
$24.2B
$4.3B
Q3 25
$24.0B
$3.7B
Q2 25
$24.0B
$3.9B
Q1 25
$24.0B
$3.5B
Q4 24
$21.6B
$4.1B
Q3 24
$20.1B
$3.7B
Q2 24
$20.8B
$3.9B
Q1 24
$21.0B
$3.4B
Debt / Equity
CTRA
CTRA
DDS
DDS
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.29×
Q1 25
0.30×
Q4 24
0.27×
Q3 24
0.16×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRA
CTRA
DDS
DDS
Operating Cash FlowLast quarter
$970.0M
$186.5M
Free Cash FlowOCF − Capex
$156.2M
FCF MarginFCF / Revenue
10.6%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
2.64×
1.44×
TTM Free Cash FlowTrailing 4 quarters
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRA
CTRA
DDS
DDS
Q4 25
$970.0M
$186.5M
Q3 25
$971.0M
$86.8M
Q2 25
$936.0M
$232.6M
Q1 25
$1.1B
$364.7M
Q4 24
$626.0M
$173.5M
Q3 24
$755.0M
$-68.4M
Q2 24
$558.0M
$244.4M
Q1 24
$856.0M
$436.5M
Free Cash Flow
CTRA
CTRA
DDS
DDS
Q4 25
$156.2M
Q3 25
$60.1M
Q2 25
$215.8M
Q1 25
$349.3M
Q4 24
$145.4M
Q3 24
$-94.3M
Q2 24
$209.2M
Q1 24
$408.2M
FCF Margin
CTRA
CTRA
DDS
DDS
Q4 25
10.6%
Q3 25
4.0%
Q2 25
14.1%
Q1 25
17.3%
Q4 24
10.2%
Q3 24
-6.3%
Q2 24
13.5%
Q1 24
19.2%
Capex Intensity
CTRA
CTRA
DDS
DDS
Q4 25
2.1%
Q3 25
1.8%
Q2 25
1.1%
Q1 25
0.8%
Q4 24
2.0%
Q3 24
1.7%
Q2 24
2.3%
Q1 24
1.3%
Cash Conversion
CTRA
CTRA
DDS
DDS
Q4 25
2.64×
1.44×
Q3 25
3.02×
1.19×
Q2 25
1.83×
1.42×
Q1 25
2.22×
1.70×
Q4 24
2.11×
1.39×
Q3 24
3.00×
-0.92×
Q2 24
2.54×
1.36×
Q1 24
2.43×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRA
CTRA

Oil And Condensate$941.0M53%
Natural Gas Production$615.0M34%
Natural Gas Liquids Reserves$206.0M12%
Other Revenues$28.0M2%

DDS
DDS

Segment breakdown not available.

Related Comparisons